Imatinib induced sweet syndrome in the patient of chronic myeloid leukemia
Journal Title: INTERNATIONAL JOURNAL OF CURRENT RESEARCH - Year 2018, Vol 10, Issue 9
Abstract
Imatinib mesylate is the first line tyrosine kinase inhibitor and the main chemotherapeutic agents currently used to treat patients with chronic myeloid leukemia (CML). Although various cutaneous reactions to this drug are well known, but only few case reports are there documenting sweet syndrome (Ayirookuzhi et al., 2005).
Authors and Affiliations
Dr. Mohini . , Dr. Nidhi . , Dr. Varun Yadav
Keywords
Related Articles
- EP ID EP403448
- DOI -
- Views 107
- Downloads 0
Synthesis, charecterization and biological evaluation of some 1, 3 and 4- Thiadiazoles schiff bases
Thiadiazoles and their analogues exhibit a wide variety of biological activities like antibacterial, antifungal, antitubercular, antidiabetic, anti-inflammatory, anti-convulsant, diuretic etc., In the present research wo...
Variations in morphology of cerebral hemispheres and their clinical implications with special reference to polygyria
Polygyria is a developmental anomaly of the brain characterized by development of numerous small gyri. It is a neuronal migration cortical organization disorder which is often sporadic or genetic but is also seen seconda...
Learning Idiosyncrasies Of The Business Students In The Selected Arab States
Learning idiosyncrasies which is interchangeably used to refer to learning preferences in this research is an important topic in education since students learning preference are part of their individuality, their idiosyn...
Comparison of serum glucose and salivary glucose in diabetic patients
Introduction: The importance of saliva for oral health is well known. Diabetes mellitus affects the salivary gland functioning and thus alters the salivary constituents. For many years the question of the presence of glu...
A clinicopathologic study of various breast lesions by Fine Needle Aspiration Cytology (FNAC) in a tertiary medical college hospital of Bangladesh
The expected and significant role of cytological diagnosis is to distinguish benign from malignant processes. FNAC of the breast has two main goals. One is to confirm a radiological and clinical benign lesion and avoid u...